Lexicon Pharma (NASDAQ: LXRX) reported Q1 EPS of ($0.20), in-line with the analyst estimate of ($0.20). Revenue for the quarter came in at $1.13 million versus the consensus estimate of $1.37 million.

For earnings history and earnings-related data on Lexicon Pharma (LXRX) click here.